Ipca Laboratories Ltd Q3FY25; 25% rise in Profits

Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals.

Financial Results:

Ipca Laboratories Ltd reported Revenues for Q3FY25 of ₹2,245.00 Crores up from ₹2,053.00 Crore year on year, a rise of 9.35%.

Total Expenses for Q3FY25 of ₹1,897.00 Crores up from ₹1,855.00 Crores year on year, a rise of 2.26%.

Consolidated Net Profit of ₹276.00 Crores up 24.89% from ₹221.00 Crores in the same quarter of the previous year.

The Earnings per Share is ₹9.78, up 37.94% from ₹7.09 in the same quarter of the previous year.